Invention Grant
- Patent Title: Antibody directed against the endothelin receptor beta sub-type
-
Application No.: US16310655Application Date: 2017-06-22
-
Publication No.: US11312780B2Publication Date: 2022-04-26
- Inventor: Didier Boquet , Frédéric Ducancel , Amaury Herbet , Narciso Costa , Jean-Philippe Hugnot
- Applicant: COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES
- Applicant Address: FR Paris
- Assignee: COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES
- Current Assignee: COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES
- Current Assignee Address: FR Paris
- Agency: Pearne & Gordon LLP
- Priority: FR1655915 20160624
- International Application: PCT/EP2017/065442 WO 20170622
- International Announcement: WO2017/220739 WO 20171228
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K16/30 ; A61P35/00 ; G01N33/574 ; A61K39/00
Abstract:
Antibodies directed against the endothelin receptor sub-type B, in particular monoclonal antibodies, a fragment or derivative thereof. The present disclosure also relates to the therapeutic, diagnostic use or as a research tool of such an antibody in the field of cancers and in particular glioblastoma.
Public/Granted literature
- US20190185574A1 ANTIBODY DIRECTED AGAINST THE ENDOTHELIN RECEPTOR BETA SUB-TYPE Public/Granted day:2019-06-20
Information query
